FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joan Smallshaw

Research Profile

Chemicals & Drugs

Living Beings

Activities & Behaviors

Bioterrorism

Procedures

Anatomy

Lung

Co-author Network

Publications

TOP 3
Ellen S Vitetta; Joan E Smallshaw; John Schindler
Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccine.
Joan E Smallshaw; Ellen S Vitetta
Ricin vaccine development.
Seth H Pincus; Joan E Smallshaw; Kejing Song; Jody Berry; Ellen S Vitetta
Passive and active vaccination strategies to prevent ricin poisoning.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joan Smallshaw (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ellen S Vitetta; Joan E Smallshaw; John Schindler
Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccine.
Clinical and vaccine immunology : CVI 2012;19(10):1697-9.
2012: Joan E Smallshaw; Ellen S Vitetta
Ricin vaccine development.
Current topics in microbiology and immunology 2012;357():259-72.
2011: Seth H Pincus; Joan E Smallshaw; Kejing Song; Jody Berry; Ellen S Vitetta
Passive and active vaccination strategies to prevent ricin poisoning.
Toxins 2011;3(9):1163-84.
2011: Patricia M Legler; Joan E Smallshaw; Ellen S Vitetta; Robert N Brey; Charles B Millard
Structure of RiVax: a recombinant ricin vaccine.
Acta crystallographica. Section D, Biological crystallography 2011;67(Pt 9):826-30.
2010: Praveena S Marconescu; Joan E Smallshaw; Laurentiu M Pop; Stephen L Ruback; Ellen S Vitetta
Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication.
Vaccine 2010;28(32):5315-22.
2010: Joan E Smallshaw; Ellen S Vitetta
A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity.
Vaccine 2010;28(12):2428-35.
2007: Joan E Smallshaw; James A Richardson; Ellen S Vitetta
RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.
Vaccine 2007;25(42):7459-69.
2006: Elaine J Coleman; Kimberly J Brooks; Joan E Smallshaw; Ellen S Vitetta
The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell lines.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(5):489-98.
2006: Xiao-Yun Liu; Laurentiu M Pop; Derry C Roopenian; Victor Ghetie; Ellen S Vitetta; Joan E Smallshaw
Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics.
International immunopharmacology 2006;6(5):791-9.
2006: Ellen S Vitetta; Joan E Smallshaw; Elaine Coleman; Hasan Jafri; Callie Foster; Robert Munford; John Schindler
A pilot clinical trial of a recombinant ricin vaccine in normal humans.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(7):2268-73.
2005: Laurentiu M Pop; Joan E Smallshaw; Thomas F Tucker; Freda K Stevenson; Ellen S Vitetta
Failure of vaccination with idiotypic protein or DNA, (+/-IL-2), the depletion of regulatory T cells, or the blockade of CTLA-4 to prolong dormancy in mice with BCL1 lymphoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(6):525-34.
2005: Joan E Smallshaw; James A Richardson; Seth Pincus; John Schindler; Ellen S Vitetta
Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin.
Vaccine 2005;23(39):4775-84.
2004: Joan E Smallshaw; Elaine Coleman; Camelia I Spiridon; Ellen S Vitetta
The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(6):419-24.
2004: Ruiqi Meng; Joan E Smallshaw; Laurentiu M Pop; Michael Yen; Xiaoyun Liu; Lien Le; Maria-Ana Ghetie; Ellen S Vitetta; Victor Ghetie
The evaluation of recombinant, chimeric, tetravalent antihuman CD22 antibodies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1274-81.
2003: Joan E Smallshaw; Victor Ghetie; Josep Rizo; John R Fulmer; Linda L Trahan; Maria-Ana Ghetie; Ellen S Vitetta
Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice.
Nature biotechnology 2003;21(4):387-91.
2002: Joan E Smallshaw; Ana Firan; John R Fulmer; Stephen L Ruback; Victor Ghetie; Ellen S Vitetta
A novel recombinant vaccine which protects mice against ricin intoxication.
Vaccine 2002;20(27-28):3422-7.